Portola pharmaceuticals, inc. (PTLA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenues:
Total revenues

26,389

29,248

36,799

28,424

22,169

15,298

14,177

4,011

6,644

9,803

3,828

3,787

5,128

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Cost of sales

4,320

29,553

2,684

4,991

7,150

12,401

4,292

1,052

336

-

155

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

26,089

29,858

25,647

33,538

35,584

49,461

40,237

66,440

60,067

68,491

55,273

49,292

30,645

56,009

87,209

44,823

58,813

59,813

48,405

52,300

39,858

34,721

31,780

28,983

28,155

22,643

18,088

20,833

17,722

9,954

13,088

Selling, general and administrative

54,418

59,980

52,050

53,855

53,034

40,617

38,792

40,214

31,541

26,903

28,856

20,329

15,021

12,884

13,556

17,044

14,751

10,881

10,071

8,912

9,005

6,950

6,424

4,937

5,241

4,769

3,907

3,708

3,039

2,879

3,059

Total operating expenses

84,827

119,391

80,381

92,384

95,768

102,479

83,321

107,706

91,944

95,654

84,284

69,621

45,666

68,893

100,765

61,867

73,564

70,694

58,476

61,212

48,863

41,671

38,204

33,920

33,396

27,412

21,995

24,541

20,761

12,833

16,147

Loss from operations

-58,438

-90,143

-43,582

-63,960

-73,599

-87,181

-69,144

-103,695

-85,300

-85,851

-80,456

-65,834

-40,538

-55,200

-91,443

-57,636

-65,306

-66,280

-55,564

-58,827

-46,504

-39,260

-35,777

-31,505

-31,024

-25,356

-19,229

-21,940

-17,653

-12,095

50,718

Interest and other (expense) income, net

-2,186

1,740

1,953

4,021

1,984

4,393

3,924

1,828

3,371

-2,290

663

-124

413

497

407

297

332

-190

406

498

-409

4

-16

155

298

294

679

342

-489

607

-956

Interest expense

8,147

8,273

7,998

8,538

6,481

6,098

5,957

4,104

2,581

3,360

3,148

3,456

1,639

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-68,771

-96,676

-49,627

-68,477

-78,096

-88,886

-71,177

-105,971

-84,510

-91,501

-82,941

-69,414

-41,764

-54,764

-91,036

-57,339

-64,974

-66,105

-55,158

-58,329

-46,913

-

-

-

-

-

-

-

-

-

-

Net income attributable to noncontrolling interest

0

0

0

-2,273

60

-338

126

223

-332

280

-5

240

-45

-

1,853

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to Portola

-68,771

-96,676

-49,627

-66,204

-78,156

-88,548

-71,303

-106,194

-84,178

-91,781

-82,936

-69,654

-41,719

-53,841

-92,889

-57,339

-64,974

-66,105

-55,158

-58,329

-46,913

-39,256

-35,793

-31,350

-30,726

-25,062

-18,550

-21,598

-18,142

-11,488

49,762

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,488

2,319

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,488

3,314

Earnings Per Share [Abstract]
Basic and diluted (in dollars per share)

-0.88

-1.24

-0.68

-0.97

-1.17

-1.34

-1.08

-1.61

-1.28

-1.44

-1.41

-1.22

-0.74

-0.95

-1.64

-1.02

-1.15

-1.24

-1.05

-1.12

-0.95

-0.82

-0.86

-0.76

-0.75

11.29

-0.53

-1.47

-12.94

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8.38

1.71

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8.38

1.67

Shares used to compute net loss per share attributable to Portola common stockholders:
Basic and diluted (in shares)

78,171

78,004

73,017

68,128

67,070

66,509

66,165

65,884

65,509

65,348

58,940

57,050

56,692

56,616

56,508

56,399

56,397

53,674

52,576

52,147

49,527

48,277

41,402

41,228

41,001

40,085

35,200

14,681

1,401

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,370

1,355

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,370

1,985

Product revenue, net
Total revenues

25,637

28,375

35,743

27,164

20,362

14,070

7,176

2,265

606

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and license revenue
Total revenues

752

873

1,056

1,260

1,807

1,228

7,001

1,746

6,038

-

-

-

5,128

13,693

9,322

4,231

8,258

4,414

2,912

2,385

2,359

2,411

2,427

2,415

2,372

2,056

2,766

2,601

3,108

738

66,865